Piroxicam in recent epidemiologic studies.
Data from nine epidemiologic studies indicate that nonsteroidal anti-inflammatory drugs as a class are much better tolerated by the gastrointestinal tract than is aspirin, and that piroxicam, specifically, is at least as well tolerated as other nonsteroidal anti-inflammatory drugs.